Trial NCT01032122

View at ClinicalTrials.gov 
Org. Study IDs: MIMM1

Last trial update was posted on 2013-04-25

MeSH Interventions

Rituximab

MeSH Conditions

Melanoma

Other Conditions

Metastatic Melanoma

Stopping Reasons

the only reason is that recruitment was not sufficient to meet the planned patient numbers, because complete remissions are still infrequent.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID